This rise in Saad’s stake underscores his pivotal role in South Africa’s business landscape, placing him among the top investors on the …
Stephen Saad
-
-
Aspen anticipates a robust second half of 2024, supported by the launch of sterile manufacturing contracts and continued growth in its active …
-
This increase cements Saad’s position in the South African business scene, placing him among the leading investors on the JSE.
-
According to data compiled by Billionaires.Africa, the market value of Saad’s stake in Aspen has increased by $52.4 million to $623.6 million.
-
Despite the recent stock dip, Saad remains a prominent investor on the Johannesburg Stock Exchange and maintains his status as one of …
- Southern Africa
Stephen Saad leads South Africa’s Aspen in game-changing $100-million Sandoz China acquisition
Discover how Saad’s audacious $100M deal is revolutionizing Aspen Pharmacare.
-
Beyond Aspen Pharmacare, Saad’s influence extends to a diverse array of companies, each representing a facet of his entrepreneurial prowess.
-
South African billionaire and pharmaceutical tycoon, Stephen Saad’s stake in Durban-based pharmaceutical company Aspen Pharmacare Holdings has declined by more than $28 …
- Southern Africa
South African billionaire Stephen Saad suffers over $100-million loss in just 72 days
Saad, who founded Aspen in 1997, owns a 12.5-percent stake, or 57,151,972 ordinary shares, in the branded pharmaceutical holding company.
-
Apart from his executive and governance roles in Aspen Pharmacare, Saad also holds a controlling 12.5-percent stake in the company.